fatigue the human capabilities that we have available to work through their inexorable maze. This same PBM is also taking the stance of deciding to not cover new therapies for acne.
So where do we go from here? It is certainly important that dermatology take a strong stand to fight for patient access to quality care and treatments for our patients. However, the approach that is taken to change the stance of PBMs will have to be one that exposes how the dollars are distributed, how PBMs control dollar distribution that can selectively benefit their interests as opposed to patients, and ultimately challenges their bottom line. Until then, the voices of individual clinicians may lead to individual changes at times, but the overall scenario will continue to evolve and erode the ability of dermatologists to optimally care for their patients. It is time for the “man behind the curtain” to be exposed on center stage.
James Q. Del Rosso DO
JDR Dermatology Research / Thomas Dermatology
Las Vegas, NV
Past President, American Acne & Rosacea Society
So where do we go from here? It is certainly important that dermatology take a strong stand to fight for patient access to quality care and treatments for our patients. However, the approach that is taken to change the stance of PBMs will have to be one that exposes how the dollars are distributed, how PBMs control dollar distribution that can selectively benefit their interests as opposed to patients, and ultimately challenges their bottom line. Until then, the voices of individual clinicians may lead to individual changes at times, but the overall scenario will continue to evolve and erode the ability of dermatologists to optimally care for their patients. It is time for the “man behind the curtain” to be exposed on center stage.
James Q. Del Rosso DO
JDR Dermatology Research / Thomas Dermatology
Las Vegas, NV
Past President, American Acne & Rosacea Society
